Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System
Sponsor: DexCom, Inc.
This NA trial investigates Diabetes Mellitus and is currently completed. DexCom, Inc. leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Jun 2018 — Jan 2019 [monthly]
Withheld
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- DexCom, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .